|Articles|October 10, 2022
Massive Bio and Perthera.ai Announce Partnership
Advertisement
Massive Bio has announced a partnership with Perthera.ai. Perthera.ai’s ranked therapy recommendations will complement Massive Bio’s screening and analysis to aid more cancer patients in finding an appropriate clinical trial.
Read more about the partnership
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
2
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
3
ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion
4
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
5